XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share
 6 Months Ended
Mar. 29, 2024
Earnings Per Share [Abstract]  
Earnings Per Share EARNINGS PER SHARE:
Basic earnings per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards.
The following table sets forth the computation of basic and diluted earnings per share attributable to the Company's stockholders (in thousands, except per share data):
Three Months EndedSix Months Ended
March 29, 2024March 31, 2023March 29, 2024March 31, 2023
Earnings:
Net income from Continuing Operations attributable
to Aramark stockholders
$53,449 $14,249 $81,985 $52,747 
Income from Discontinued Operations, net of tax— 41,792 — 77,445 
Net income attributable to Aramark stockholders$53,449 $56,041 $81,985 $130,192 
Shares:
Basic weighted-average shares outstanding
262,841 260,673 262,447 260,063 
Effect of dilutive securities2,441 1,864 2,328 1,930 
Diluted weighted-average shares outstanding
265,282 262,537 264,775 261,993 
Basic earnings per share attributable to Aramark stockholders:
Income from Continuing Operations$0.20 $0.05 $0.31 $0.20 
Income from Discontinued Operations— 0.16 — 0.30 
Basic earnings per share attributable to Aramark
stockholders
$0.20 $0.21 $0.31 $0.50 
Diluted earnings per share attributable to Aramark stockholders:
Income from Continuing Operations$0.20 $0.05 $0.31 $0.20 
Income from Discontinued Operations— 0.16 — 0.30 
Diluted earnings per share attributable to Aramark
stockholders
$0.20 $0.21 $0.31 $0.50 
Share-based awards to purchase 10.2 million and 8.3 million shares were outstanding for the three months ended March 29, 2024 and March 31, 2023, respectively, but were not included in the computation of diluted earnings per common share, as their effect would have been antidilutive. In addition, PSUs related to 1.4 million and 0.8 million shares were outstanding for the three months ended March 29, 2024 and March 31, 2023, respectively, but were not included in the computation of diluted earnings per common share, as the performance targets were not yet met.
Share-based awards to purchase 11.5 million and 8.4 million shares were outstanding for the six months ended March 29, 2024 and March 31, 2023, respectively, but were not included in the computation of diluted earnings per common share, as their effect would have been antidilutive. In addition, PSUs related to 1.4 million and 0.8 million shares were outstanding for the six months ended March 29, 2024 and March 31, 2023, respectively, but were not included in the computation of diluted earnings per common share, as the performance targets were not yet met.